KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹289 Cr | ₹219 Cr | ₹177 Cr | ₹152 Cr | ₹161 Cr |
What is the latest Total Current Liabilities ratio of KOPRAN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹289 Cr |
| Mar2024 | ₹219 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹152 Cr |
| Mar2021 | ₹161 Cr |
How is Total Current Liabilities of KOPRAN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹289 Cr | 32.23 | |
| Mar2024 | ₹219 Cr | 23.48 | |
| Mar2023 | ₹177 Cr | 16.75 | |
| Mar2022 | ₹152 Cr | -5.66 | |
| Mar2021 | ₹161 Cr | - | |
Compare Total Current Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹593.8 Cr | -6.5% | -10.8% | -26.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -6.5% |
-10.8% |
-26.6% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses